Literature DB >> 18540741

The effect of attributional processes concerning medication taking on return of fear.

Mark B Powers1, Jasper A J Smits, Diana Whitley, Alexander Bystritsky, Michael J Telch.   

Abstract

In this investigation, the authors examined the effect of attributional processes concerning medication taking on return of fear following exposure-based treatment. Participants (87% undergraduate students and 13% community volunteers) displaying marked claustrophobic fear (N = 95) were randomly allocated to a waitlist condition, a psychological placebo condition, a 1-session exposure-based treatment, or the same exposure treatment given in conjunction with an inactive pill. Attributions concerning medication taking were manipulated by further randomly assigning participants in the exposure-based treatment plus pill condition to 1 of 3 instructional sets immediately following treatment completion and posttreatment assessment: (1) The pill was described as a sedating herb that likely made exposure treatment easier; (2) the pill was described as a stimulating herb that likely made exposure treatment more difficult; or (3) the pill was described as a placebo that had no effect on exposure treatment. Return of fear rates for the 3 conditions were 39%, 0%, and 0%, respectively. Moreover, the deleterious effects of the sedation instructions were mediated by reduced self-efficacy. These findings highlight the importance of assessing patient attributions regarding the improvements achieved with combined exposure-based and pharmacological treatments for anxiety disorders. (c) 2008 APA, all rights reserved

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540741     DOI: 10.1037/0022-006X.76.3.478

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  9 in total

1.  Mind over PMDD: A Glimpse into the Process of Pharmacotherapy-Psychotherapy Combination Treatment.

Authors:  Gili W Adler Nevo; Colman Nefsky
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-05

2.  Changes in self-efficacy and outcome expectancy as predictors of anxiety outcomes from the CALM study.

Authors:  Lily A Brown; Joshua F Wiley; Kate Wolitzky-Taylor; Peter Roy-Byrne; Cathy Sherbourne; Murray B Stein; Greer Sullivan; Raphael D Rose; Alexander Bystritsky; Michelle G Craske
Journal:  Depress Anxiety       Date:  2014-03-11       Impact factor: 6.505

Review 3.  Threat reappraisal as a mediator of symptom change in cognitive-behavioral treatment of anxiety disorders: a systematic review.

Authors:  Jasper A J Smits; Kristin Julian; David Rosenfield; Mark B Powers
Journal:  J Consult Clin Psychol       Date:  2012-06-11

4.  Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.

Authors:  Michael W Otto; R Kathryn McHugh; Kathleen M Kantak
Journal:  Clin Psychol (New York)       Date:  2010-06-08

5.  Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data.

Authors:  Mark B Powers; Johnna L Medina; Stephanie Burns; Brooke Y Kauffman; Marie Monfils; Gordon J G Asmundson; Allison Diamond; Christa McIntyre; Jasper A J Smits
Journal:  Cogn Behav Ther       Date:  2015-02-23

Review 6.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

7.  Over the Edge: Extending the duration of a reconsolidation intervention for spider fear.

Authors:  Anna I Filmer; Jacqueline Peters; Lara A Bridge; Renée M Visser; Merel Kindt
Journal:  Transl Psychiatry       Date:  2022-06-23       Impact factor: 7.989

8.  Attributions of change and self-efficacy in a randomized controlled trial of medication and psychotherapy for problem drinking.

Authors:  Katherine Schaumberg; Alexis Kuerbis; Jon Morgenstern; Frederick Muench
Journal:  Behav Ther       Date:  2012-07-24

9.  Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia.

Authors:  Michael J Telch; Aleksandra K Bruchey; David Rosenfield; Adam R Cobb; Jasper Smits; Sandra Pahl; F Gonzalez-Lima
Journal:  Am J Psychiatry       Date:  2014-10       Impact factor: 18.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.